Eric B Suhler

Summary

Country: USA

Publications

  1. ncbi request reprint Presumed teratoma-associated paraneoplastic retinopathy
    Eric B Suhler
    Arch Ophthalmol 121:133-7. 2003
  2. ncbi request reprint HLA-B27-associated uveitis: overview and current perspectives
    Eric B Suhler
    Casey Eye Institute, Oregon Health and Science University, and Portland VA Medical Center, Ophthalmology Service, 97239, USA
    Curr Opin Ophthalmol 14:378-83. 2003
  3. ncbi request reprint A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes
    Eric B Suhler
    Uveitis and Retina Divisions, Casey Eye Institute, 3375 SW Terwilliger Blvd, Portland, OR 97239, USA
    Arch Ophthalmol 123:903-12. 2005
  4. pmc Genotype analysis of polymorphisms in autoimmune susceptibility genes, CTLA-4 and PTPN22, in an acute anterior uveitis cohort
    Tammy M Martin
    Oregon Health and Science University, Portland, OR, USA
    Mol Vis 15:208-12. 2009
  5. ncbi request reprint Characteristics and visual outcome of patients with retinal vasculitis
    Jennifer H Ku
    Department of Ophthalmology, Public Health, Oregon Health and Science University, Portland, Oregon, USA
    Arch Ophthalmol 130:1261-6. 2012
  6. pmc Characterization of serous retinal detachments in uveitis patients with optical coherence tomography
    Annamieka Simmons-Rear
    Casey Eye Institute, Oregon Health and Science University, Portland, OR, USA
    J Ophthalmic Inflamm Infect 2:191-7. 2012
  7. pmc Azathioprine for ocular inflammatory diseases
    Sirichai Pasadhika
    Department of Ophthalmology, Oregon Health and Science University, Portland, Oregon, USA
    Am J Ophthalmol 148:500-509.e2. 2009
  8. ncbi request reprint The course of retinal vasculitis
    Amro Ali
    Department of Ophthalmology, Oregon Health and Science University, Portland, Oregon, USA
    Br J Ophthalmol 98:785-9. 2014
  9. pmc Pharmacotherapy of scleritis: current paradigms and future directions
    Robert M Beardsley
    Oregon Health and Science University, Casey Eye Institute, 3375 SW Terwilliger Blvd, Portland, OR 97239, USA
    Expert Opin Pharmacother 14:411-24. 2013
  10. doi request reprint Uveitis in patients with autoimmune hepatitis
    Lyndell L Lim
    Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, USA
    Am J Ophthalmol 147:332-338.e1. 2009

Collaborators

Detail Information

Publications27

  1. ncbi request reprint Presumed teratoma-associated paraneoplastic retinopathy
    Eric B Suhler
    Arch Ophthalmol 121:133-7. 2003
  2. ncbi request reprint HLA-B27-associated uveitis: overview and current perspectives
    Eric B Suhler
    Casey Eye Institute, Oregon Health and Science University, and Portland VA Medical Center, Ophthalmology Service, 97239, USA
    Curr Opin Ophthalmol 14:378-83. 2003
    ....
  3. ncbi request reprint A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes
    Eric B Suhler
    Uveitis and Retina Divisions, Casey Eye Institute, 3375 SW Terwilliger Blvd, Portland, OR 97239, USA
    Arch Ophthalmol 123:903-12. 2005
    ..We conducted a prospective, open-label phase 2 clinical trial to assess the effectiveness of infliximab in treating refractory autoimmune uveitis...
  4. pmc Genotype analysis of polymorphisms in autoimmune susceptibility genes, CTLA-4 and PTPN22, in an acute anterior uveitis cohort
    Tammy M Martin
    Oregon Health and Science University, Portland, OR, USA
    Mol Vis 15:208-12. 2009
    ..In this study we have analyzed SNPs in PTPN22 and CTLA-4 in patients with AAU...
  5. ncbi request reprint Characteristics and visual outcome of patients with retinal vasculitis
    Jennifer H Ku
    Department of Ophthalmology, Public Health, Oregon Health and Science University, Portland, Oregon, USA
    Arch Ophthalmol 130:1261-6. 2012
    ..To examine the characteristics and visual outcome in 207 patients with retinal vasculitis...
  6. pmc Characterization of serous retinal detachments in uveitis patients with optical coherence tomography
    Annamieka Simmons-Rear
    Casey Eye Institute, Oregon Health and Science University, Portland, OR, USA
    J Ophthalmic Inflamm Infect 2:191-7. 2012
    ....
  7. pmc Azathioprine for ocular inflammatory diseases
    Sirichai Pasadhika
    Department of Ophthalmology, Oregon Health and Science University, Portland, Oregon, USA
    Am J Ophthalmol 148:500-509.e2. 2009
    ..To evaluate treatment outcomes of azathioprine for noninfectious ocular inflammatory diseases...
  8. ncbi request reprint The course of retinal vasculitis
    Amro Ali
    Department of Ophthalmology, Oregon Health and Science University, Portland, Oregon, USA
    Br J Ophthalmol 98:785-9. 2014
    ..To determine if characteristics of retinal vasculitis correlate with ocular complications, or the response to different lines of treatment...
  9. pmc Pharmacotherapy of scleritis: current paradigms and future directions
    Robert M Beardsley
    Oregon Health and Science University, Casey Eye Institute, 3375 SW Terwilliger Blvd, Portland, OR 97239, USA
    Expert Opin Pharmacother 14:411-24. 2013
    ..Because scleritis can be refractory to standard treatment, knowledge of the body of available and emerging therapies is paramount and is reviewed here...
  10. doi request reprint Uveitis in patients with autoimmune hepatitis
    Lyndell L Lim
    Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, USA
    Am J Ophthalmol 147:332-338.e1. 2009
    ..To report seven cases of uveitis occurring in patients with autoimmune hepatitis (AIH), raising the possibility that uveitis may be an extrahepatic feature of AIH...
  11. ncbi request reprint Histopathological features of conjunctival sarcoid nodules using noninvasive in vivo confocal microscopy
    Michael S Wertheim
    Casey Eye Institute, Oregon Health and Science University, 3375 SW Terwilliger Blvd, Portland, OR 97239, USA
    Arch Ophthalmol 123:274-6. 2005
  12. pmc The role of choroidal and retinal biopsies in the diagnosis and management of atypical presentations of uveitis
    Lyndell L Lim
    Casey Eye Institute, Oregon Health and Sciences University, Portland Oregon, USA
    Trans Am Ophthalmol Soc 103:84-91; discussion 91-2. 2005
    ..The most common indication is atypical uveitis, in which a diagnosis of malignancy or infection may be suspected. Here, we describe our experience at the Casey Eye Institute...
  13. ncbi request reprint Biologic therapies for inflammatory eye disease
    Lyndell Lim
    Casey Eye Institute, Oregon Health and Science University, 3375 SSW Terwilliger Boulevard, Portland, Oregon 97239, USA
    Clin Experiment Ophthalmol 34:365-74. 2006
    ....
  14. pmc The future of uveitis treatment
    Phoebe Lin
    Casey Eye Institute, Oregon Health and Science University, Portland, Oregon Electronic address
    Ophthalmology 121:365-76. 2014
    ..Novel approaches of delivering a therapeutic substance include, but are not limited to, the use of small interfering RNA, viral and nonviral gene therapy, and microparticle or viscous gel sustained-release drug-delivery platforms. ..
  15. doi request reprint Cytomegalovirus retinitis in the absence of AIDS
    Seema Gupta
    Casey Eye Institute, Oregon Health and Science University, Portland, OR 97239, USA
    Can J Ophthalmol 48:126-9. 2013
    ..The purpose of this study was to evaluate systemic and ophthalmic features associated with Cytomegalovirus (CMV) retinitis in immunocompetent patients...
  16. pmc Possible association between scleritis and lymphoma
    Lynnelle K Smith
    Casey Eye Institute, Oregon Health and Science University, 3375 SW Terwilliger Blvd, Portland, Oregon 97239 4197, USA
    Br J Ophthalmol 91:1728-9. 2007
  17. pmc Long-term follow-up of patients treated with multiple fluocinolone acetonide implants for noninfectious uveitis
    Rebekah C Allen
    Casey Eye Institute, Oregon Health and Science University, 3375 SW Terwilliger Blvd, Portland, OR, 97239, USA
    J Ophthalmic Inflamm Infect 2:177-82. 2012
    ..To evaluate long-term outcomes in eyes undergoing exchange of fluocinolone acetonide intravitreal implants for noninfectious uveitis...
  18. pmc Patients with retinal vasculitis rarely suffer from systemic vasculitis
    James T Rosenbaum
    Department of Ophthalmology, Oregon Health and Science University, Portland, OR 97239, USA
    Semin Arthritis Rheum 41:859-65. 2012
    ..Systemic vasculitis is often mistakenly assumed to be a common cause of retinal vasculitis. We sought to determine the relationship between retinal vasculitis and systemic vasculitis...
  19. ncbi request reprint In vivo confocal microscopy of keratic precipitates
    Michael S Wertheim
    Casey Eye Institute, Oregon Health and Science University, Portland 97201, USA
    Arch Ophthalmol 122:1773-81. 2004
    ..To evaluate the heterogeneity of keratic precipitates (KP) in varying subtypes of uveitis by in vivo confocal microscopy (IVCM)...
  20. doi request reprint Management of fluocinolone implant dissociation during implant exchange
    Steven Yeh
    Department of Ophthalmology, Casey Eye Institute, Oregon Health Sciences University, Portland, Oregon 97239, USA
    Arch Ophthalmol 127:1218-21. 2009
    ..Patients undergoing FA explantation or exchange should be counseled regarding this potential complication prior to surgery...
  21. doi request reprint Hepatitis B vaccine and uveitis: an emerging hypothesis suggested by review of 32 case reports
    Frederick W Fraunfelder
    Casey Eye Institute, Portland, Oregon 97239, USA
    Cutan Ocul Toxicol 29:26-9. 2010
    ..To report a possible association between hepatitis B vaccine and uveitis...
  22. ncbi request reprint Toxoplasmosis retinochoroiditis and elevated intraocular pressure: a retrospective study
    Andrew C Westfall
    Department of Ophthalmology, Casey Eye Institute, Oregon Health and Science University, Portland, Oregon 97201, USA
    J Glaucoma 14:3-10. 2005
    ..To report the prevalence of abnormal intraocular pressure (IOP) in patients with toxoplasmosis retinochoroiditis and to determine risk factors for such abnormality...
  23. ncbi request reprint Mycophenolate mofetil for the treatment of scleritis
    H Nida Sen
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892 1857, USA
    Ophthalmology 110:1750-5. 2003
    ..To evaluate the usefulness of mycophenolate mofetil (MMF) (CellCept, Roche, Nutley, NJ), an antimetabolite immunosuppressant with a selective antiproliferative effect on T and B lymphocytes, for the treatment of scleritis...
  24. ncbi request reprint Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration
    Robert B Nussenblatt
    The National Eye Institute, Laboratory of Immunology, NIH, Building 10, 10 Center Drive, Bethesda, MD, USA
    J Autoimmun 21:283-93. 2003
    ..These studies suggest that anti-IL-2 receptor blockade could be useful in the treatment of Th1-mediated autoimmune conditions...
  25. ncbi request reprint Bilateral uveitis in a patient with autoimmune lymphoproliferative syndrome
    Wee Kiak Lim
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892 1857, USA
    Am J Ophthalmol 139:562-3. 2005
    ..We report a case of autoimmune lymphoproliferative syndrome (ALPS) presenting with bilateral uveitis...
  26. pmc A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease
    Ronald R Buggage
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892 1857, USA
    Ocul Immunol Inflamm 15:63-70. 2007
    ..To investigate the safety and efficacy of daclizumab (Zenapax, humanized anti-Tac, HAT) in controlling the ocular manifestations of Behçet's disease...
  27. doi request reprint Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
    John H Kempen
    Center for Preventive Ophthalmology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Ophthalmic Epidemiol 15:47-55. 2008
    ....